Form 4: Zeo ScientifiX Director Steven Jerry Glauser Receives Stock Options
SEC Form 4
Director Steven Jerry Glauser of Zeo ScientifiX, Inc. was granted stock options for 125,000 shares on July 11, 2024, according to a Form 4 filing.
Summary
- Steven Jerry Glauser, a director of Zeo ScientifiX, Inc. (ZEOX), received stock options for 125,000 shares on July 11, 2024.
- The options have an exercise price of $2.35.
- These options vest in equal monthly installments over 18 months from the grant date and are subject to the terms of the company's 2021 Equity Incentive Plan.
- The options expire on July 11, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The grant of stock options is a standard practice and generally viewed as a positive incentive for management.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders, incentivizing him to work towards increasing the company's value.
- The vesting schedule encourages long-term commitment from the director.
Industry Context
Stock option grants are a common practice to incentivize company directors and align their interests with shareholders. The specifics of the vesting schedule and exercise price are typical considerations in such grants.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign, aligning management's interests with theirs.
- The director is incentivized to improve company performance to increase the value of the options.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of stock options grant |
| 07/15/2024 | Date of Form 4 filing |
| 08/11/2024 | First date of exercisability |
| 07/11/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.